SCHEMBL26971387

SCHEMBL26971387

CSc1ncc(C)c(C2CCN(C)CC2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 1/20 0.35
▸ JAK1 P23458 1/20 0.34
▸ TLR9 Q9NR96 1/20 0.34
▸ TLR8 Q9NR97 1/20 0.34
▸ TLR7 Q9NYK1 1/20 0.34
▸ DRD2 P14416 1/20 0.33
▸ DRD1 P21728 1/20 0.33
▸ HTR2A P28223 1/20 0.33
▸ DRD3 P35462 1/20 0.33
▸ QDPR P09417 1/20 0.33
▸ FGFR4 P22455 1/20 0.33
▸ TGFBR1 P36897 1/20 0.33
▸ ACVR1 Q04771 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ NOS3 P29474 1/20 0.33
▸ NOS1 P29475 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ USP7 Q93009 1/20 0.33
▸ MAP4K1 Q92918 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21126284 0.66 QDPR (0.45) TLR9TLR8TLR7DRD3QDPR
SCHEMBL13058451 0.65 L3MBTL1 (0.33) LMNA
SCHEMBL26185481 0.65 TMEM97 (0.51) KCNH2
SCHEMBL3753768 0.65 L3MBTL1 (0.33) LMNA
SCHEMBL30534004 0.65 TMEM97 (0.51) KCNH2
SCHEMBL15345115 0.65 MAP4K4 (0.42) TLR9TLR8TLR7QDPRUSP7
SCHEMBL1014948 0.65 MEN1 (0.46) MEN1KMT2A
SCHEMBL12051523 0.65 ALDH1A1 (0.45) NOS3NOS1MEN1KMT2ALMNA
SCHEMBL31591033 0.65 ALDH1A1 (0.45) NOS3NOS1MEN1KMT2ALMNA
SCHEMBL30597066 0.64 MERTK (0.41) JAK1MEN1KMT2ABRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11858916-B2 GLP-1 receptor agonists and uses thereof PFIZER INC. (US) 2024-01-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11858916-B2 GLP-1 receptor agonists and uses thereof GLP1R, GIPR, GCGR ALOX15 2282/4885JAK1 1939/4885TLR9 802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback